Loading…
Bayer and CrossBay Medical Inc. announced a development and option to license agreement to develop and produce a single-handed inserter combined with Bayer's hormonal intrauterine systems (IUSs), using CrossBay's CrossGlide technology. The deal was announced on November 30, 2023.